While CRISPR technology holds tremendous promise, several challenges remain:
Precision: Achieving the necessary precision to avoid off-target effects. Delivery Mechanisms: Developing effective ways to deliver the CRISPR components to the specific cells that need editing. Regulatory Hurdles: Navigating the complex regulatory landscape to gain approval for clinical use.
